Reducing opportunistic infections such as TB in children with HIV could save both lives and money
24-year study of spring emergence of Fowler’s Toads creates model for predicting climate-change effects
The ability to predict when toads come out of hibernation in southern Canada could provide valuable insights into the future effects of climate change on a range of animals and plants.
Researchers discover new genetic mutation linked to osteonecrosis of the hip
Scientists at the Research Institute of McGill University Health Centre (RI-MUHC) have discovered a new genetic mutation linked to osteonecrosis of the hip, specifically the femoral head – the spherical-shaped mass at the top of the femur. This breakthrough could allow doctors to identify and treat the disease before symptoms arise and potentially avoid hip replacements.
Génome Québec is happy to report that Québec has achieved excellent results in the 5th cycle of the Genomic Applications Partnership Program (GAPP).
Research sheds new light on what constitutes healthy aging of the brain
The inability to remember details, such as the location of objects, begins in early midlife (the 40s) and may be the result of a change in what information the brain focuses on during memory formation and retrieval, rather than a decline in brain function, according to a study by McGill University researchers.
Research underlines importance of computational power in future neurological breakthrough
Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer’s disease (LOAD), identifying its first physiological signs.
World-renowned pain specialist and medical cannabis researcher Dr. Mark Ware, director of clinical research at the Alan Edwards Pain Management Unit of the McGill University Health Centre (MUHC), has been nominated vice-chair of an important federal task force that will provide guidance to the Canadian government as it prepares to introduce legislation to legalize marijuana in spring 2017.
Neuron cell death may be caused by overactive immune system
A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at McGill University have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease.
Couche-Tard founder gives $4 million to McGill for groundbreaking research on intellectual disabilities
It’s all math: How Professor Alan Evans is using cutting-edge statistics to unravel the complexity of brain disorders.
When Alan Evans was starting out in the 1970s, researchers didn’t ask the boss to foot their bar tab. But that’s exactly what some of the coders in his Montreal Neurological Institute lab recently proposed: a 9-to-5 Saturday hackathon, held in an Irish pub a few blocks from the McGill University campus.
EMC working with McGill to support data storage and visualization technologies to help with the NeuroHub project
The Canadian research team that helped spearhead the international brain-mapping project known as BigBrain is about to get a major boost in its effort to produce sharply higher-resolution brain maps, thanks to technology from EMC Corporation.
Study reveals the impact of night work
You cross paths with him at the break of dawn in the corridors of the Metro. He looks bleary-eyed and pallid. This worker’s night shift just ended. His body clocks are out of sync with one another, and, imperceptibly, they’re also out of sync with his environment. In the long run, this night owl could be at greater risk of developing cardiovascular, autoimmune diseases or certain types of cancer.
Newly named Gerald Bronfman Department of Oncology recognizes family’s enduring support
In recognition of the Bronfman family’s enduring support for oncology programs and research at McGill University, the Faculty of Medicine’s Department of Oncology has been named the Gerald Bronfman Department of Oncology, in honour of one of the family’s major benefactors.
Antibiotic resistance represents a major challenge in treating pathogenic bacterial infections.
Now, researchers at McGill University have discovered a possible target for fighting back against resistant bacteria.